Table 3.

Clinical endpoints after LAAC until hospital discharge and given medication. (TIA: transient ischaemic attack; DAPT: dual antiplatelet therapy; VKA: Vitamin K antagonist; NOAC: Non-Vitamin K antagonist oral anticoagulants).

Clinical Endpoint	Value
pericardial efflusion	0 (0%)
TIA	0 (0%)
stroke	0 (0%)
systemic embolism	0 (0%)
device embolism	0 (0%)
death	0 (0%)
medication
aspirin	29 (97%)
clopidogrel	28 (93%)
ticagrelor	0 (0%)
prasugrel	0 (0%)
DAPT	27 (90%)
VKA	0 (0%)
NOAC	3 (10%)
NOAC + antiplatelet	2 (7%)